Evolving consensus for immunomodulatory therapy in non-infectious uveitis during the COVID-19 pandemic

Affiliations

• ¹ National Healthcare Group Eye Institute, Tan Tock Seng Hospital, Singapore, Singapore [email protected] [email protected] [email protected].
• ² Singapore Eye Research Institute, Singapore, Singapore.
• ³ School of Material Science and Engineering, Nanyang Technological University, Singapore, Singapore.
• ⁴ Department of Medical Retina and Uveitis, Moorfields Eye Hospital, NHS Foundation Trust, London, United Kingdom.
• ⁵ Department of Ophthalmology, University of Washington, Seattle, USA.
• ⁶ UCLA Stein Eye Institute and Department of Ophthalmology, David Geffen School of Medicine at UCLA, University of California, Los Angeles, USA.
• ⁷ Wilmer Eye Institute, Johns Hopkins University School of Medicine, USA, Baltimore.
• ⁸ Department of Ophthalmology, Kyorin University School of Medicine, Tokyo, New South Wales, Japan.
• ⁹ Flinders University College of Medicine and Public Health, Adelaide, Australia.
• ¹⁰ Department of Ophthalmology, Director Save Sight Institute, The University of Sydney, Sydney, Pennsylvania, Australia.
• ¹¹ Department of Ophthalmology, Massachusetts Eye and Ear Infirmary and Harvard Medical School, Boston, USA.
• ¹² Eye Unit, MyungSung Christian Medical Center, MCM General Hospital and MyungSung Medical School, Addis Ababa, Ethiopia.
• ¹³ Department of Ophthalmology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland.
• ¹⁴ Shroff Eye Centre, New Delhi, India.
• ¹⁵ Department of Ophthalmology,, Sorbonne University, Paris, France.
• ¹⁶ Byers Eye Institute, Stanford Medical School, Stanford, USA.
• ¹⁷ Advanced Eye Centre, Postgraduate Institute of Medical Education (PGIMER), Chandigarh, India.
• ¹⁸ Department of Ophthalmology ZNA Middelheim, Antwerp, Belgium.
• ¹⁹ Centre of Ophthalmology, University of Tuebingen, Tuebingen, Germany.